Common adverse reactions (adults and pediatric patients 12 years) and WEGOVY side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and nasopharyngitis
These are two separate categories of litigation involving the same medications
What this means: Semaglutide = strong appetite + fullness effect via GLP-1 Tirzepatide + added GIP receptor action + GLP-1, which may translate into greater weight reduction These medications are used for adults with obesity receiving semaglutide or obesity receiving tirzepatide, and are effective for weight management in these populations
As of my knowledge cutoff in September 2021, the FDA has not approved CJC-1295 for use as a type of anti-aging treatment
They slow down gastric emptying, leading to prolonged digestion
She said advocacy groups are working with the CMS to provide evidence and rationale to update that coverage determination. TRICARE, which covers military service members, families and retirees, had been covering the drugs but is pulling back